<bill session="116" type="s" number="977" updated="2019-06-04T09:18:01Z">
  <state datetime="2019-04-01">REFERRED</state>
  <status>
    <introduced datetime="2019-04-01"/>
  </status>
  <introduced datetime="2019-04-01"/>
  <titles>
    <title type="official" as="introduced">A bill to address the high cost of prescription drugs.</title>
    <title type="short" as="introduced">Transparent Drug Pricing Act of 2019</title>
    <title type="short" as="introduced">Transparent Drug Pricing Act of 2019</title>
    <title type="display">Transparent Drug Pricing Act of 2019</title>
  </titles>
  <sponsor bioguide_id="S001217"/>
  <cosponsors>
    <cosponsor bioguide_id="H001089" joined="2019-04-01"/>
  </cosponsors>
  <actions>
    <action datetime="2019-04-01">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2019-04-01" state="REFERRED">
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="SSHR" name="Senate Health, Education, Labor, and Pensions" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Asia"/>
    <term name="Canada"/>
    <term name="Consumer affairs"/>
    <term name="Employee benefits and pensions"/>
    <term name="Europe"/>
    <term name="France"/>
    <term name="Germany"/>
    <term name="Health care costs and insurance"/>
    <term name="Health care coverage and access"/>
    <term name="Inflation and prices"/>
    <term name="Japan"/>
    <term name="Prescription drugs"/>
    <term name="Retail and wholesale trades"/>
    <term name="United Kingdom"/>
  </subjects>
  <amendments/>
  <committee-reports/>
</bill>
